Effects of docetaxel on antigen presentation-related functions of human monocyte-derived dendritic cells

Hiroshi Nakashima1, Akira Tasaki, Makoto Kubo

  • 1Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashiku, Fukuoka City, 812-8582, Japan.

Abstract

Insights

Docetaxel (TXT) at low therapeutic doses impairs the directional movement of dendritic cells (DCs), which are crucial for antigen presentation. This finding is important for understanding TXT

Area of Science:

  • Immunology
  • Cell Biology
  • Pharmacology

Background:

  • Docetaxel (TXT) is a chemotherapy drug that stabilizes microtubules, impacting cellular functions.
  • TXT is increasingly used with immunotherapy for advanced cancers.
  • The effect of clinically relevant TXT concentrations on dendritic cell (DC) function is not well understood.

Purpose of the Study:

  • To investigate the impact of TXT on human monocyte-derived dendritic cells (Mo-DCs) at concentrations below 10(-6) M.
  • To assess TXT's influence on Mo-DC viability, phagocytosis, molecule expression, and motility.
  • To determine how TXT affects antigen presentation-related functions of Mo-DCs.

Main Methods:

  • Generated immature Mo-DCs (imMo-DCs) and mature Mo-DCs (mMo-DCs) in vitro.
  • Treated Mo-DCs with varying concentrations of TXT.
  • Assessed cellular viability, phagocytosis, and expression of antigen presentation molecules (CCR1, CCR7).
  • Evaluated Mo-DC chemotactic motility towards chemokines (MIP-1alpha, MIP-3beta) and microtubule structure.

Main Results:

  • TXT concentrations below 10(-7) M did not significantly affect Mo-DC viability, phagocytosis, or key molecule expression.
  • TXT at concentrations below 10(-9) M significantly suppressed the directional motility of both imMo-DCs and mMo-DCs.
  • No significant changes in microtubule structure were observed at TXT concentrations below 10(-8) M, but reduced podosome formation was noted in imMo-DCs.

Conclusions:

  • Different concentrations of TXT differentially affect Mo-DC functions.
  • TXT, even at relatively low therapeutic doses, disrupts the chemotactic motility of Mo-DCs.
  • This disruption of Mo-DC motility may have implications for the efficacy of TXT-based cancer therapies, particularly when combined with immunotherapy.